Role of capsaicin-sensitive afferents in fever and cytokine responses during systemic and local inflammation in rats.
OBJECTIVE
Peripheral afferents play an important role in fever. In the present study, we investigated the role of capsaicin-sensitive afferents in fever and cytokine responses during systemic (induced by intraperitoneal lipopolysaccharide, LPS) and local (induced by injection of Freund's incomplete adjuvant, FIA, into the paw) inflammation.


METHODS
Fevers in rats (8-10 weeks of age) whose capsaicin-sensitive afferents were depleted by neonatal capsaicin (50 mg/kg) treatment were compared to those of rats treated as neonates with vehicle. To investigate a possible involvement of cytokines, plasma levels of interleukin-6 (IL-6) and tumor necrosis factor (TNF) were measured during LPS- and FIA-induced fever in rats after capsaicin-induced desensitization. Body temperature was measured by biotelemetry. IL-6 and TNF bioactivities in plasma were determined using bioassays.


RESULTS
The initial but not the late phase of LPS (50 microg/kg)-induced fever was markedly higher (approximately 1.0 degree C) in rats whose capsaicin-sensitive neurons were destroyed by neonatal capsaicin treatment. Capsaicin-induced desensitization also resulted in significantly higher plasma levels of IL-6 and TNF 1 but not 4 h after LPS challenge. In contrast, the day after injection with FIA (0.1 ml), rats treated with capsaicin had significantly lower body temperatures compared with vehicle-treated animals. No differences were found in plasma levels of IL-6 and TNF between capsaicin- and vehicle-treated animals in response to FIA.


CONCLUSIONS
These data indicate that the role of capsaicin-sensitive afferents in fever depends on the type of inflammatory response. During systemic inflammation, capsaicin-sensitive afferents may be involved in modulating fever by regulating the levels of pyrogenic cytokines. During local inflammation, the late phase of fever is partially mediated via capsaicin-sensitive afferents.
Gourine
A V
AV
Institute of Physiology, National Academy of Sciences of Belarus, Minsk, Belarus.
Rudolph
K
K
Korsak
A S
AS
Kubatko
J
J
Tesfaigzi
J
J
Kozak
W
W
Kluger
M J
MJ
D000344:Afferent Pathways / Q000187:drug effects / Q000503:physiopathology; D000818:Animals; D000831:Animals, Newborn; D001284:Atrophy; D002211:Capsaicin / Q000494:pharmacology* / Q000633:toxicity; D016207:Cytokines / Q000097:blood / Q000378:metabolism*; D003714:Denervation; D005106:Exploratory Behavior / Q000502:physiology; D005334:Fever / Q000209:etiology* / Q000503:physiopathology; D005528:Foot; D005620:Freund's Adjuvant / Q000008:administration & dosage / Q000633:toxicity; D007249:Inflammation / Q000139:chemically induced / Q000150:complications / Q000276:immunology / Q000503:physiopathology*; D007274:Injections, Intraperitoneal; D015850:Interleukin-6 / Q000097:blood; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000633:toxicity; D008168:Lung / Q000294:innervation / Q000473:pathology; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology*; D009619:Nociceptors / Q000502:physiology*; D010538:Peritonitis / Q000139:chemically induced / Q000150:complications / Q000276:immunology / Q000503:physiopathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D001743:Urinary Bladder / Q000294:innervation / Q000473:pathology
D016207:Cytokines; D015850:Interleukin-6; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha; D005620:Freund's Adjuvant; D002211:Capsaicin